SII may cut Covishield's monthly production by half amid demand slump
The Hindu
New Delhi, Dec 7 (PTI) With not enough orders for Covishield from the central government, Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said the company is looking at slashing monthly
New Delhi, Dec 7 (PTI) With not enough orders for Covishield from the central government, Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said the company is looking at slashing monthly production of vaccines by at least 50 per cent.
SII has written to the government to seek clarity on its requirement, if any, for normal two doses for eligible people in the country and also on booster doses.
"I am actually in a dilemma that I never imagined... we are producing 250 million doses a month but the good news is that India has covered up a large part of its population and we would have completed all our orders to the Ministry of Health in a week's time," Poonawalla said in an interview to CNBC-TV18.